The clinical trials told one story. When patients stopped semaglutide in controlled research settings, they regained roughly ...

The relaunched site will cover longevity research, therapeutics, biomarkers, clinics, regulation, capital and data ...

Despite a growing emphasis on quality-of-life (QoL) endpoints and patient-reported outcomes in cancer trials, the reporting ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Add Yahoo as a preferred source to see more of our stories on Google. The trial for the man accused of brutally murdering a Scottsdale woman in her home back in 2015 is underway. Allison Feldman, 31, ...

E.W. Scripps is selling the channel to the parent company of Law&Crime, which wants Court TV to have a bigger streaming presence. By Lauren Hirsch Court TV, which brings viewers into courtrooms for ...

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

In December, Edwards Lifesciences persuaded CMS to publish an updated tracking sheet for TAVR national coverage analysis, causing the agency to reconsider its previous stance on covering transcatheter ...

The judge overseeing Matthew Farwell’s criminal case in federal court denied a motion from his defense attorneys seeking to move his forthcoming trial out of Massachusetts over what they dubbed ...